市场见解

Universal Biosensors (ASX:UBI) share price dips despite latest update

The Universal Biosensors Inc. (ASX: UBI) share price is edging lower today despite the company making further expansions overseas.
The post Universal Biosensors (ASX:UBI) share price dips despite latest update appeared first on The Motley Fool Australia. –

A doctor looks unsure, indicating share price uncertainty for ASX medical companies

The Universal Biosensors Inc (ASX: UBI) share price is edging lower today. As of writing, shares in the medical diagnostics company are trading for 73 cents each, down 1.3%. By comparison, the S&P/ASX All Ordinaries Index (ASX: XAO) is 0.02% lower.

Today’s price movement comes after the company announced another deal to distribute one of its products – this one in South Africa.

Let’s take a closer look at today’s news and what it means for the Universal Biosensors share price.

What’s up with the Universal Biosensors share price?

In a statement to the ASX, Universal Biosensors advised it has entered a nonexclusive agreement with Vicard SA for the distribution of its wine testing platform device, Sentia, in South Africa. The deal is for 3 years.

Vicard SA is an importer of products necessary for wine production into South Africa. It has been in operation for more than 20 years.

This is the third such deal for the Sentia product. The company recently announced distribution deals in Chile and the 美国证券市场. The Universal Biosensors share price rose 6% on the former deal and fell on the latter.

Sentia is a portable, wine-testing device that delivers results in less than 60 seconds. The test measures the amount of free sulphur dioxide present in a wine product. Free sulphur dioxide needs to be present in wine for bacterial stability.

Management commentary

Universal Biosensors CEO John Sharman said:

Securing distribution in South Africa is another step forward in the commercialisation of Sentia globally. Vicard SA has 20 years of experience supplying high quality resources to the South African wine industry and there are 500 wineries which will now have the opportunity to experience Sentia.

Along with the current capability we believe the possibility of Sentia’s future testing capability for glucose, fructose, malic acid and others will add significant value to the winemaking industry. We are negotiating terms with a number of key industry players around the world and look forward to reporting additional distribution partnerships in due course.

Vicard SA CEO Michael Fernandez added:

I am thrilled to be bringing Sentia to the South African wine industry. The initial reaction from my customers has been very positive and they understand the unique benefits the system offers.

Universal Biosensors share price

Over the past 12 months, the Universal Biosensors share price has increased 279%. In fact, just over the last month, the company’s value has appreciated 28.6%. On 9 April, the share price went up 36% in one day after a medical-related update.

The Universal Biosensors share price has a market capitalisation of $127.8 million.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

See The 5 Stocks

*Returns as of February 15th 2021

More reading

Motley Fool contributor Marc Sidarous has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

The post Universal Biosensors (ASX:UBI) share price dips despite latest update appeared first on The Motley Fool Australia.

随时随地,交易世界!

移动APP平台,拥有 12 个市场的 50,000 多种全球上市证券(全球市值超过 70%),直接在您的 Android 或 iOS 设备上即可操作。

与独有的交易理念和投资分析工具相结合,帮助您在我们 12 个全球市场中的几乎所有金融工具上找到可操作的见解,从而帮助您优化交易策略。

推荐给您的朋友

向您的朋友推荐Monex并赠予他们免费使用我们交易工具的机会

我们尊重您的隐私,只会向您的朋友发送一封邮件 

与您的朋友分享

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!